John Walter Hanna
President, CEO & DirectorMr. John Walter Hanna, Jr. is President, Chief Executive Officer & Director of CareDx, Inc since April 15, 2024. He served as General Manager of Endocrinology, Breast Cancer and Lymphoma at Veracyte, Inc. since January 1, 2021 and had been Chief Commercial Officer since February 28, 2017 until January 01, 2021. Mr. Hanna oversees sales, marketing and managed care for Veracyte. Mr. Hanna joined Veracyte in 2011 and served as vice president of marketing and has held several leadership roles during his tenure. In his tenure, he has helped define clear patient-centric value propositions for Veracyte's genomic tests, leading to broad physician adoption and health plan reimbursement. His efforts are driving Veracyte's anticipated 2016 revenue of over 60 million. Mr. Hanna held management positions in business strategy and development at IBM and Humana. Mr. Hanna joined Veracyte in 2011 and has held several leadership roles during his tenure. Mr. Hanna was Chief Executive Officer & Director of Apton Biosystems, Inc. He is a commercial leader and health policy expert with experience in revenue-generating and management roles across the health insurance, healthcare IT and molecular diagnostics industries. Mr. Hanna holds a Bachelor of Science degree in Political Science from Hampden-Sydney College in Virginia and an M.B.A. from the University of Miami School of Business.
Positions
- Company NameCareDx, Inc.Stock CodeCDNAPositionPresident, CEO & DirectorColleagues
- MDMichael D. GoldbergIndependent Chairman
- KSKeith S. KennedyCFO & COO
- JAJeffrey A. NovackGeneral Counsel & Secretary
- JMJessica MengChief Commercial Officer
- KRKashif RathoreChief Technology Officer
- CMChristine M. CournoyerIndependent Director
- RBR. Bryan RiggsbeeIndependent Director
- FEFred E. CohenIndependent Director
